These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20968025)

  • 1. [Evolution and perspectives in the surgical treatment of ovarian cancer].
    Cherenkov VG; Shpenkova AA
    Vopr Onkol; 2010; 56(4):450-5. PubMed ID: 20968025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment outcomes for advanced ovarian cancers with peritoneal dissemination].
    Oe S; Hasegawa K; Ichikawa R; Torii Y; Kato R; Komiyama S; Udagawa Y
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):591-7. PubMed ID: 21498987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Super radical surgery of advanced ovarian cancers (stages III and IV)].
    Michel G; Castaigne D; Morice P; Lhommé C; Duviliard P
    Contracept Fertil Sex; 1997 Jun; 25(6):V-XI. PubMed ID: 9280543
    [No Abstract]   [Full Text] [Related]  

  • 4. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
    Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C
    J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Argument about the management and prognostic factors of borderline ovarian tumor].
    Hao M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):7-10. PubMed ID: 21429426
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
    Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneum as the first-line of defense in carcinomatosis.
    Sugarbaker PH
    J Surg Oncol; 2007 Feb; 95(2):93-6. PubMed ID: 17262739
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined organ resection in cytoreductive surgery for ovarian cancer].
    Goto T; Takeda S
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():531-4. PubMed ID: 15535302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The potential and feasibility of conservative therapy for the early stages of ovarian cancerĭ].
    Bakhidze EV; Gulo EI; Maksimov SIa; Chepik OF; Gederim MN
    Vopr Onkol; 1999; 45(6):674-9. PubMed ID: 10703521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Lan C; Li Y; Liu J
    Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary borderline serous neoplasia of the peritoneum.
    Gandhi H; Bickerton NJ
    J Obstet Gynaecol; 2004 Feb; 24(2):187-8. PubMed ID: 14766470
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical management of women with ovarian cancer.
    Cooper A; DePriest P
    Semin Oncol; 2007 Jun; 34(3):226-33. PubMed ID: 17560984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.
    Gouy S; Chereau E; Custodio AS; Uzan C; Pautier P; Haie-Meder C; Duvillard P; Morice P
    J Am Coll Surg; 2010 Apr; 210(4):509-14. PubMed ID: 20347745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maximal cytoreductive surgery in patients with advanced ovarian cancer for improving the prognosis].
    Ohwada M; Izumi A; Fujiwara H; Suzuki M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():535-9. PubMed ID: 15535303
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive surgery and ovarian cancer.
    Chi DS; Barakat RR
    J Clin Oncol; 2006 May; 24(15):2395-6; author reply 2396-7. PubMed ID: 16710043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endoscopic management of gynecological malignancies: an update. 2007].
    Canis M; Jardon K; Niro J; Rabischong B; Bourdel N; Botchorishvili R; Pouly JL; Mage G
    Bull Acad Natl Med; 2007 Oct; 191(7):1357-65; discussion 1365-6. PubMed ID: 18447057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes.
    Bristow RE; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Armstrong DK
    Gynecol Oncol; 2009 Dec; 115(3):334-8. PubMed ID: 19766295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.